Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

GLMDGLMD
4 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in GALMED PHARMACEUTICALS LTD

CITADEL ADVISORS LLC holds 86,851 shares of GLMD (GALMED PHARMACEUTICALS LTD), worth $48,315 as of 2026-Q2. The position was increased (+663.1% shares).

Current Value

$48,315

Current Shares

86,851

Total Value Change

-$22,879

Total Shares Change

+36,359

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
86,851
+663.1%
$48,3150.0%$0.56
22
2026-Q1
Decreased
11,382
-70.2%
$5,5000.0%$0.49
0
2025-Q4
Decreased
38,177
-24.4%
$28,6520.0%$0.75
0
2025-Q3
New
50,492
-
$71,1940.0%$1.38
32

Other major holders of GLMD: TWO SIGMA INVESTMENTS, LP, Schonfeld Strategic Advisors LLC, MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used